AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Novartis AG Director's Dealing 2018

Mar 23, 2018

940_dirs_2018-03-23_a9d38239-4f86-4677-89bc-fbead9068b28.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Intellia Therapeutics, Inc. (NTLA)
CIK: 0001652130
Period of Report: 2018-03-16

Reporting Person: Novartis Institutes for BioMedical Research, Inc. (10% Owner)
Reporting Person: NOVARTIS AG (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4277073	Direct

Footnotes

F1: The shares are held directly by Novartis Institutes for BioMedical Research, Inc. ("NIBRI"). NIBRI is an indirect wholly-owned subsidiary of Novartis AG.